Rosemont Pharmaceuticals buys specialist pharmaceutical firm Lucis Pharma
The acquisition presents exciting opportunities for accelerated growth as it expands Rosemont's portfolio and grants access to new…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
16 Jun 23
The acquisition presents exciting opportunities for accelerated growth as it expands Rosemont's portfolio and grants access to new…
PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates
16 Jun 23
Collaboration to make use of Confo’s unique suite of ConfoBody-enabled antibody discovery technologies on two GPCR targets
16 Jun 23
Despite nearly 20 years of availability, biosimilars show worldwide adoption rate of only 14% in initiative-tracked countries, while…
PharmaceuticalsConsulting, Training and Other Pharmaceutical Services
15 Jun 23
Blue Water will acquire Zontivity, Trezix, Nalfon, Conjupri, Otovel and Cetraxal, which are approved by the US Food…
PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates
15 Jun 23
CAL02 is a non-biological bacterial virulence neutraliser and anti-infective agent intended to treat severe community-acquired bacterial pneumonia as…
PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates
15 Jun 23
With the approval, US-based UPSIDE Foods is now working with USDA to obtain a grant of inspection (GOI)…
15 Jun 23
Under the partnership, Vial will support Nielsen for the Phase 3, randomised, double-blind, placebo-controlled clinical study of Candin…
15 Jun 23
The collaboration involves combining Cullgen's uSMITE targeted protein degradation platform, which utilises novel E3 ligands, with Astellas' expertise…
15 Jun 23
The approval allows for the investigation of ALE.C04 both as a standalone treatment and in combination with pembrolizumab…
15 Jun 23
Over the past three years of Pepsi Zero Sugar®, Lay's®, Gatorade™ and UEFA Champions League partnership, "Team of…